St Jude, IBM collaborate on new cardiac device monitor and programmer :
This article was originally published in Clinica
St Jude Medical and the information technology giant IBM have developed a new system designed to manage patients implanted with cardiac devices such as defibrillators and pacemakers more efficiently. The Merlin patient care system, approved by the FDA in April, is a portable computer which allows doctors to retrieve and analyse patient information during routine follow-up visits and to make programming changes to the implanted devices. As part of the companies' seven-year collaborative agreement, IBM will continue to act as the business liaison with the third party contract manufacturer who will be responsible for the manufacturing of the system. St Jude begins worldwide distribution of the product immediately.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.